These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6805330

  • 1. Intrauterine pressure changes during dysmenorrhea therapy.
    Smith RP, Powell JR.
    Am J Obstet Gynecol; 1982 Jun 01; 143(3):286-92. PubMed ID: 6805330
    [Abstract] [Full Text] [Related]

  • 2. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E, von Fischer B.
    Adv Prostaglandin Thromboxane Res; 1980 Jun 01; 8():1487-93. PubMed ID: 6769316
    [Abstract] [Full Text] [Related]

  • 3. The objective evaluation of dysmenorrhea therapy.
    Smith RP, Powell JR.
    Am J Obstet Gynecol; 1980 Jun 01; 137(3):314-9. PubMed ID: 6990763
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone].
    Kunz J, Schneider W.
    Schweiz Med Wochenschr; 1981 Sep 26; 111(39):1451-5. PubMed ID: 6794145
    [Abstract] [Full Text] [Related]

  • 5. Mefenamic acid in dysmenorrhea.
    Pulkkinen MO, Kaihola HL.
    Acta Obstet Gynecol Scand; 1977 Sep 26; 56(1):75-6. PubMed ID: 320811
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
    Fraser IS, Pearse C, Shearman RP, Elliott PM, McIlveen J, Markham R.
    Obstet Gynecol; 1981 Nov 26; 58(5):543-51. PubMed ID: 7029369
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
    Hébert JG, Le Morvan P, Bourgouin J.
    Clin Ther; 1986 Nov 26; 8(3):329-35. PubMed ID: 3521860
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
    Roy S.
    Obstet Gynecol; 1983 May 26; 61(5):628-32. PubMed ID: 6835617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
    López Rosales C, Cisneros Lugo JH, Romo Enciso LJ, García Sandoval MG.
    Ginecol Obstet Mex; 1989 Jul 26; 57():196-201. PubMed ID: 2486951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distribution analysis of intrauterine pressure in nonpregnant dysmenorrheic women.
    Smith RP.
    Am J Obstet Gynecol; 1984 Jun 01; 149(3):271-3. PubMed ID: 6731505
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of primary dysmenorrhea. Comparative study of ibuprofen and mefenamic acid].
    Pedrón Nuevo DN.
    Ginecol Obstet Mex; 1995 Jan 01; 63():4-9. PubMed ID: 7896157
    [Abstract] [Full Text] [Related]

  • 17. Mefenamic acid, ibuprofen, and dysmenorrhea.
    Smith RP, Powell JR.
    Obstet Gynecol; 1984 Jun 01; 63(6):867-8. PubMed ID: 6374541
    [No Abstract] [Full Text] [Related]

  • 18. A rationale for the treatment of dysmenorrhea.
    Csapo AI.
    J Reprod Med; 1980 Oct 01; 25(4 Suppl):213-21. PubMed ID: 7001020
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors].
    Lundström V.
    Lakartidningen; 1979 Feb 21; 76(8):614-6. PubMed ID: 105214
    [No Abstract] [Full Text] [Related]

  • 20. Mefenamic acid for dysmenorrhea in patients with intrauterine devices.
    Budoff PW.
    JAMA; 1979 Aug 17; 242(7):616-7. PubMed ID: 448996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.